Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced ...

Expanded Dose Exploration in Part A and Dose Escalation in Part B of BEAM-302 Phase 1/2 Study in Alpha-1 Antitrypsin ...

Indian researchers identify blood markers for early diabetes and kidney risk, enabling personalized treatment and timely interventions.

Iowa's oldest living person died at the age of 115 in 2023. Ames native Colleen Larson turned 100 years old this fall, a ...

The presentation will provide two-year follow-up data from the landmark BOOSTB4 Phase I/II clinical study. Notably, the results demonstrate that more than 50% of the treated patients experienced zero ...

As the only Australian-bred horse in the field, Half Yours was the sentimental favourite for many. Not as well known was the ...

In October 2025, the U.S. Food and Drug Administration (FDA) granted approval to multiple new cancer therapies and supportive ...

Detailed price information for Scilex Holding Co. (SCLX-Q) from The Globe and Mail including charting and trades.

Lovers of beloved P-22, aka the Hollywood Cat, are readying his final close-up, a life-sized sculpture of the world famous ...

The group alleges selective use of field trial results to project higher yields and early maturation while ICAR scientists defend the evaluation process as transparent and scientifically sound ...

Draig Therapeutics Appoints Seasoned Neuroscience Leader Ivana Magovčević-Liebisch as President and Chief Executive Officer ...

Presented positive data from Phase 1 clinical trials with ARV-102 in healthy volunteers and patients with Parkinson’s disease - ...